Impact of hepatitis B virus X protein on the DNA damage response during hepatocarcinogenesis

Area of Science:

• Hepatology
• Molecular Biology
• Cancer Research

Background:

• Hepatocellular carcinoma (HCC) is a major global health concern, frequently linked to chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections.
• HBV-associated HCC remains prevalent, particularly in Asia, with the HBV X protein (HBX) implicated in hepatocarcinogenesis.
• Existing research on HBX-mediated signaling pathways in liver cancer is conflicting, hindering a clear understanding of its role.

Purpose of the Study:

• To review the multifaceted roles of HBX in DNA damage repair mechanisms during HCC development.
• To elucidate the mechanistic significance of HBX in the early stages of hepatocarcinogenesis.
• To consolidate current understanding and address discrepancies in HBX-associated signaling pathways.

Main Methods:

• Literature review focusing on studies investigating HBX interactions with DNA damage response proteins.
• Analysis of research examining HBX's influence on cell cycle regulation and apoptosis.
• Compilation of data on HBX-induced alterations in key signaling pathways (e.g., MAPK, Akt, JAK/STAT).

Main Results:

• HBX exhibits complex effects on DNA damage response, including inactivation of early damage responses and sensitization to apoptosis.
• HBX interferes with centrosome replication, leading to chromosomal abnormalities and micronuclei formation.
• HBX modulates various oncogenic signaling pathways, such as Ras/Raf/MAPK, Akt, and JAK/STAT, contributing to uncontrolled cell proliferation.

Conclusions:

• HBX plays a critical role in hepatocarcinogenesis by dysregulating DNA damage repair and activating pro-cancerous signaling pathways.
• Understanding HBX's intricate interactions with cellular machinery is crucial for deciphering the early events in HBV-associated HCC.
• Further research into HBX's functions may reveal novel therapeutic targets for preventing or treating liver cancer.